Business ❯ Finance ❯ Corporate Finance
Novo Nordisk Pfizer Sun Pharmaceutical Industries Cipla Eli Lilly Merck Company Performance AstraZeneca Bristol Myers Squibb Vertex Pharmaceuticals Aurobindo Pharma Johnson & Johnson Dr Reddy's Laboratories Bristol-Myers Squibb Pfizer Inc. Merck & Co. Biosimilars Cardinal Health Reig Jofre Citius Pharmaceuticals Vaccine Development Biontech Eli Lilly and Company Mankind Pharma Ajanta Pharma Grifols Sun Pharmaceutical Industries Ltd AbbVie Novartis AG GSK Sanofi Biotech Companies GlaxoSmithKline Pharmaceuticals ANI Pharmaceuticals AbbVie Inc. Alkem Laboratories Financial Guidance BioMarin Pharmaceutical Inc. Cipla Ltd Dr Reddy's Sun Pharmaceutical Industries Limited Financial Performance Sales Performance Innovative Medicines Revenue Growth
Want to see what podcasts are saying about this topic? Search across 145K+ podcasts. Explore Radar
Management pointed to stronger non‑Covid drug sales and the $10 billion Metsera deal as steps to offset weakening revenue from the vaccine plus antiviral Paxlovid.
